BOSTON and SHANGHAI, June 18, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that the first patient has been dosed in a Phase 1b clinical trial of AZD5004/ECC5004 in China
Clinical Kidney Journal, 15
Plus d'infos Mission novembre 2025 2026-01-02T13:01:17+01:00 2026-01-02T13:01:17+01:00 Patrick_Grard Novembre 2025: une importante mission pluridisciplinaire Novembre 2025: une importante mission multidisciplinaire mene par notre prsidente, Batrice Van Frachen, sest partage entre Datcha, Sokod et Lom
If your headache is accompanied by vision changes, chest pain, severe nausea, or difficulty breathing, seek immediate medical attention rather than assuming it's a normal adjustment response